Portage Biotech Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Portage Biotech Inc acquires majority interest in Biohaven Pharmaceutical Holding Company Limited
Portage Biotech Inc:Says it has acquired about 54 percent equity in Biohaven Pharmaceutical Holding Company Limited, for C$3.5 million, payable as C$1.75 million upfront and the balance in three installments over the next eleven months.Says Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
Latest Developments for Portage Biotech Inc
Latest Key Developments in Biotechnology
- Advaxis Inc completes $17 mln financing
- FDA accepts IND application for Radius Health's investigational drug RAD1901 being developed for potential use in Metastatic Breast Cancer
- Amarantus BioScience Holdings, Inc submits orphan drug designation application to US FDA for treatment of Retinal Artery occlusion with product candidate MANF
- Carna Biosciences Inc expects extraordinary loss for Q4 2014 and issues consolidated full-year outlook for FY 2014
- Share this
- Digg this